regeneron glp-1 flags promising obesity data for olatorepatide | Pharmaceutical Regeneron's Semaglutide Plus Trevogrumab Combo

doi:10.1038/nature01889

Besouw MT, Hulstijn-Dirkmaat GM, van der Rijken RE, Cornelissen EA, van Dael CM, Vande Walle J, Lilien MR, Levtchenko EN (2010) Neurocognitive functioning in school-aged cystinosis patients

Clin Nutr (2011) 30(4):52432.10.1016/j.clnu.2011.01.007 132 GerspachACSteinertRESchonenbergerLGraber-MaierABeglingerC

Administering the wrong dose or frequency can lead to suboptimal results or, in rare cases, unwanted side effects

This article examines the evidence, explores why periods may change during GLP-1 therapy, and clarifies when medical review is appropriate

In response, continuous-flow microreactor synthesis has been proposed to overcome these issues, offering improved mixing, uniform heating, and real-time monitoring to enhance reproducibility [170]